During the recent session, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s traded shares were 0.49 million, with the beta value of the company hitting 1.75. At the last check today, the stock’s price was $0.76, reflecting an intraday gain of 13.39% or $0.09. The 52-week high for the QNRX share is $6.18, that puts it down -713.16 from that peak though still a striking 43.42% gain since the share price plummeted to a 52-week low of $0.43. The company’s market capitalization is $3.85M, and the average intraday trading volume over the past 10 days was 2.34 million shares, and the average trade volume was 3.34 million shares over the past three months.
Quoin Pharmaceuticals Ltd ADR (QNRX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. QNRX has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.43.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) trade information
Quoin Pharmaceuticals Ltd ADR (QNRX) registered a 13.39% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 13.39% in intraday trading to $0.76, hitting a weekly high. The stock’s 5-day price performance is 36.21%, and it has moved by -7.03% in 30 days. Based on these gigs, the overall price performance for the year is -83.73%. The short interest in Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) is 19172.0 shares and it means that shorts have 0.2 day(s) to cover.
Quoin Pharmaceuticals Ltd ADR (QNRX) estimates and forecasts
Statistics show that Quoin Pharmaceuticals Ltd ADR has outperformed its competitors in share price, compared to the industry in which it operates. Quoin Pharmaceuticals Ltd ADR (QNRX) shares have gone up 31.30% during the last six months, with a year-to-date growth rate more than the industry average at 78.73% against 16.60.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -194.79%. While earnings are projected to return 78.42% in 2025.
QNRX Dividends
Quoin Pharmaceuticals Ltd ADR is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s Major holders
Quoin Pharmaceuticals Ltd ADR insiders own 2.45% of total outstanding shares while institutional holders control 5.89%, with the float percentage being 6.03%.
